UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide

Attard, G; Antonarakis, ES; (2016) Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide. Nature Reviews Urology , 13 (12) pp. 697-698. 10.1038/nrurol.2016.212. Green open access

[thumbnail of Attard_Antonarakis edited version_ed.pdf]
Preview
Text
Attard_Antonarakis edited version_ed.pdf - Accepted Version

Download (550kB) | Preview
Type: Article
Title: Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/nrurol.2016.212
Publisher version: https://doi.org/10.1038/nrurol.2016.212
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Androstenes, Antineoplastic Agents, Drug Resistance, Neoplasm, Humans, Male, Phenylthiohydantoin, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: https://discovery.ucl.ac.uk/id/eprint/10067212
Downloads since deposit
152Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item